6,7-Disubstituted-4-anilinoquinazoline: Design, Synthesis and Anticancer Activity as a Novel Series of Potent Anticancer Agents
Pharmaceutical Sciences · 02.10.2020 · 27 (2) · 209-218
DOI: 10.34172/ps.2020.72 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences, online erschienen am 02.10.2020. Verfasst von Fatemeh Azmian Moghadam und 3 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Epidermal Growth Factor Receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) are responsible for several pathological conditions such as the development of different kinds of tumors. The combined inhibition of both signal transduction pathways seems to be a promising novel approach for cancer treatment.
Methods
In this study, novel 4-anilinoquinazoline derivatives with various substituents on-7 position of quinazoline moiety were designed, synthesized, and evaluated for their antiproliferative activity against A431 and HU02 cell lines.
Results
Compounds 8a, 8d, and 8f displayed the most potent anticancer activities against A431(IC50 = 1.78 μM, 8.25 μM, and 7.18 μM, respectively) in comparison with reference standards(erlotinib IC50=8.31 μM and vandetanib IC50=10.62 μM). Molecular docking studies proved that8a as the most potent compound could be efficiently accommodated in the ATP binding site ofEGFR and VEGFR-2 through the formation of essential hydrogen bonds between quinazolineN1 atom and the Met796 backbone of EGFR as well as the Cys919 backbone of VEGFR-2 with a distance of 1.94 Å and 1.398 Å, respectively.
Conclusion
Compound 8a as the most potent compound with morpholine and 3-bromoaniline at the 7 and 4 positions of quinazoline scaffold, respectively, deserves more study and structural optimization as an anticancer agent.
Zitieren
APA
Moghadam, F. A., Evazalipour, M., Kefayati, H., & Ghasemi, S. (2020). 6,7-Disubstituted-4-anilinoquinazoline: Design, Synthesis and Anticancer Activity as a Novel Series of Potent Anticancer Agents. Pharmaceutical Sciences, 27(2), 209-218. https://doi.org/10.34172/ps.2020.72
Vancouver
Moghadam FA, Evazalipour M, Kefayati H, Ghasemi S. 6,7-Disubstituted-4-anilinoquinazoline: Design, Synthesis and Anticancer Activity as a Novel Series of Potent Anticancer Agents. Pharmaceutical Sciences. 2020;27(2):209-218. doi:10.34172/ps.2020.72
BibTeX
@article{Moghadam2020,
author = {Moghadam, Fatemeh Azmian and Evazalipour, Mehdi and Kefayati, Hassan and Ghasemi, Saeed},
title = {6,7-Disubstituted-4-anilinoquinazoline: Design, Synthesis and Anticancer Activity as a Novel Series of Potent Anticancer Agents},
journal = {Pharmaceutical Sciences},
year = {2020},
volume = {27},
number = {2},
pages = {209--218},
doi = {10.34172/ps.2020.72}
}
EUVIMED